Literature DB >> 10495791

Vascular expression of polycystin.

M D Griffin1, V E Torres, J P Grande, R Kumar.   

Abstract

Autosomal dominant polycystic kidney disease (AD-PKD) is predominantly caused by mutations of the gene PKD1, which encodes a large protein, polycystin, of unknown function. A variety of arterial abnormalities occur with increased prevalence in ADPKD patients. Using an antiserum against the nonduplicated region of the polycystin protein, immunostaining of vascular smooth muscle cells was detected in normal adult elastic arteries. Partial digestion of tissue slices with nonspecific proteases greatly enhanced this staining. Similar enhancement was seen with specific elastase digestion. Immunostaining for smooth muscle actin was not affected by elastase. Antiserum preadsorbed with peptide antigen gave no staining. In specimens of intracranial aneurysms, aortic dissections, and dolichoectatic arteries from thirteen patients with ADPKD, immunostaining of variable intensity for polycystin was demonstrated in arterial smooth muscle cells and myofibroblasts, along with disruption of elastic laminae. Further elastase digestion did not significantly alter staining patterns. Intracranial aneurysms from patients without ADPKD also showed a variable degree of immunostaining with polycystin antisera in the same distribution. The expression of polycystin in arterial smooth muscle suggests a direct pathogenic role for ADPKD-related mutations in the arterial complications of this disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 10495791     DOI: 10.1681/ASN.V84616

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  51 in total

1.  Hypertension in Autosomal Dominant Polycystic Kidney Disease: A Clinical and Basic Science Perspective.

Authors:  Shobha Ratnam; Surya M Nauli
Journal:  Int J Nephrol Urol       Date:  2010

Review 2.  Non-selective cationic channels of smooth muscle and the mammalian homologues of Drosophila TRP.

Authors:  D J Beech; K Muraki; R Flemming
Journal:  J Physiol       Date:  2004-07-22       Impact factor: 5.182

3.  Dissecting thoracoabdominal aortic aneurysm in a 15-year-old boy with polycystic kidney disease and other risk factors.

Authors:  Jerzy Wojtowicz; Wojciech Szczepanski; Artur Bossowski
Journal:  Pediatr Cardiol       Date:  2012-05-11       Impact factor: 1.655

Review 4.  Ciliary dysfunction in polycystic kidney disease: an emerging model with polarizing potential.

Authors:  Robert J Kolb; Surya M Nauli
Journal:  Front Biosci       Date:  2008-05-01

Review 5.  An approach to cystic kidney diseases: the clinician's view.

Authors:  Christine E Kurschat; Roman-Ulrich Müller; Mareike Franke; David Maintz; Bernhard Schermer; Thomas Benzing
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

Review 6.  Transient receptor potential channels in the vasculature.

Authors:  Scott Earley; Joseph E Brayden
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

Review 7.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

Review 8.  Polycystins and renovascular mechanosensory transduction.

Authors:  Amanda Patel; Eric Honoré
Journal:  Nat Rev Nephrol       Date:  2010-07-13       Impact factor: 28.314

9.  Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes.

Authors:  Almira Kurbegovic; Olivier Côté; Martin Couillard; Christopher J Ward; Peter C Harris; Marie Trudel
Journal:  Hum Mol Genet       Date:  2010-01-06       Impact factor: 6.150

10.  PKD1 haploinsufficiency is associated with altered vascular reactivity and abnormal calcium signaling in the mouse aorta.

Authors:  Nicole Morel; Greet Vandenberg; Ali K Ahrabi; Nathalie Caron; Fanny Desjardins; Jean-Luc Balligand; Shigeo Horie; Olivier Devuyst
Journal:  Pflugers Arch       Date:  2008-08-05       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.